The tiny shell protecting the HIV virus resembles a slightly rounded ice cream cone, but there is nothing sweet about it. More than 40 million people worldwide live with AIDS because of this virus, ...
The tiny shell protecting the HIV virus resembles a slightly rounded ice cream cone, but there is nothing sweet about it. More than 40 million people worldwide live with AIDS because of this virus, ...
Elona Toska, MSc, DPhil, explores drivers of HIV in pregnant women and young mothers: biology, relationships, and postpartum treatment drop-off. Drawing on global data, Toska examined HIV incidence ...
Researchers at the German Center for Infection Research (DZIF) at Heidelberg University Hospital have decoded a previously unknown mechanism by which HIV-1 selects its integration targets in the human ...
Researchers revealed that HIV integrase forms structural filaments within the viral capsid, enabling viral infectivity. The discovery uncovers a new drug target, opening possibilities for ...
•Nigeria has recorded remarkable progress in the fight against mother-to-child HIV transmission through expanded access to ART and improved testing and counselling during pregnancy. However, stigma, ...
In the quest to overcome quality-of-life altering side effects linked to combination antiretroviral therapy (cART) in people with HIV, a team of Johns Hopkins researchers has developed a new way to ...
Single-pill treatment proves as effective at suppressing virus as multi-pill therapy, while long-acting preventive injections are increasingly available ...
A recent study confirms lenacapavir's effectiveness against HIV and highlights the capsid as a promising drug target despite resistance.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results